Skip to main content
Surgical Case Reports logoLink to Surgical Case Reports
. 2025 Aug 22;11(1):25-0268. doi: 10.70352/scrj.cr.25-0268

A Case of Laparoscopic Distal Gastrectomy after Failure of Laparoscopic Gastric Antral Devascularization for Gastric Antral Vascular Ectasia

Kozue Matsuishi 1, Taisuke Yagi 1, Ryota Omura 1, Tomo Horinouchi 1, Toshihiko Yusa 1, Takayoshi Kaida 1, Yuki Kiyozumi 1, Kenji Shimizu 1, Kensuke Yamamura 1, Katsunori Imai 1,
PMCID: PMC12445353  PMID: 40979440

ABSTRACT

INTRODUCTION

Gastric antral vascular ectasia (GAVE) is a condition characterized by clusters of dilated capillaries in the gastric antrum, leading to gastrointestinal bleeding. Although massive hemorrhage is rare, some cases present with recurrent minor bleeding, which can make endoscopic hemostasis challenging. Here, we report a case of GAVE that was refractory to argon plasma coagulation (APC) and required surgical intervention.

CASE PRESENTATION

A 74-year-old man with end-stage renal disease who was on hemodialysis was referred to our hospital for evaluation of refractory anemia. Upper gastrointestinal endoscopy revealed the characteristic “watermelon stomach” appearance, with radially and longitudinally distributed dilated capillaries in the gastric antrum, leading to a diagnosis of GAVE. Despite undergoing APC 4 times, his anemia persisted. Given the refractory nature of the condition, surgical intervention was considered. To preserve the stomach, we initially performed laparoscopic gastric antral devascularization to reduce the blood flow to the affected area. Intraoperatively, dilated marginal vessels were observed along the greater curvature of the gastric antrum. The marginal artery was ligated along the greater curvature from the watershed area to the pylorus and pyloric ring. Indocyanine green (ICG) fluorescence imaging revealed delayed enhancement in the marginal artery resection area, indicating reduced perfusion. However, after a 2-month postoperative observation period, no improvement in the anemia was observed, and follow-up endoscopy revealed no significant changes in the gastric antral lesions. Consequently, a laparoscopic distal gastrectomy was performed. Following the procedure, the anemia stabilized, and the postoperative course was uneventful.

CONCLUSIONS

Gastric antral devascularization was ineffective for the treatment of GAVE, even when combined with ICG blood flow assessment. For refractory GAVE unresponsive to endoscopic therapy, a distal gastrectomy appears to be the most effective treatment.

KEYWORDS: gastric antral vascular ectasia, gastrointestinal hemorrhage, laparoscopic distal gastrectomy

Abbreviations

APC

argon plasma coagulation

EGD

esophagogastroduodenoscopy

GAVE

gastric antral vascular ectasia

ICG

indocyanine green

INTRODUCTION

Gastric antral vascular ectasia (GAVE) is a disease characterized by clusters of dilated capillaries in the gastric antrum, leading to gastrointestinal bleeding.1,2) Although massive hemorrhage is rare, intermittent bleeding can occur, sometimes necessitating an endoscopic intervention. Argon plasma coagulation (APC) is the standard endoscopic treatment; however, some cases are refractory to endoscopic hemostasis.3) Here, we report a case of APC-resistant GAVE in which laparoscopic gastric antral devascularization was performed but proved ineffective, and a laparoscopic distal gastrectomy was ultimately required.

CASE PRESENTATION

A 74-year-old man with end-stage renal disease secondary to glomerulonephritis was undergoing maintenance hemodialysis. He had a history of chronic renal anemia. However, his hemoglobin level decreased to 5.3 g/dL, and a fecal occult blood test performed at a previous hospital was positive. As gastrointestinal bleeding was suspected, he was referred to our institution for further evaluation. Esophagogastroduodenoscopy (EGD) revealed the characteristic “watermelon stomach” appearance with radially and longitudinally distributed dilated capillaries in the gastric antrum, leading to a diagnosis of GAVE (Fig. 1A). No active bleeding was observed during the EGD, and lower gastrointestinal endoscopy and small-bowel capsule endoscopy failed to identify an alternative bleeding source. Contrast-enhanced CT did not reveal any definitive source of bleeding but demonstrated mild dilation of the right gastroepiploic artery and vein (Fig. 1B). Based on these findings, his anemia was suspected to be caused by bleeding from the GAVE lesions, and treatment with APC was performed. Although APC was conducted 4 times, the vasodilation persisted, and the patient required repeated blood transfusions for anemia. Consequently, a surgical intervention was recommended. Although a gastrectomy was considered, the patient strongly preferred to preserve the stomach. Therefore, we decided to perform vascular decompression from the viewpoint of organ preservation, and laparoscopic gastric antral devascularization was carried out. An intraperitoneal inspection revealed dilation of the marginal vessels along the greater curvature of the gastric antrum. The marginal artery and vein were ligated and divided along the greater curvature from the watershed area to the pylorus and pyloric ring. The blood flow in the lesser curvature was preserved because of concerns about ischemia in the pylorus (Fig. 2A). Indocyanine green (ICG) fluorescence imaging revealed delayed enhancement in the marginal artery resection area, indicating reduced perfusion (Fig. 2B and 2C). There was concern that the complete absence of enhancement could lead to complications such as partial gastric wall necrosis. Therefore, the procedure was concluded with the expectation of reduced perfusion, and the postoperative course was managed with close monitoring of anemia progression. The postoperative course was uneventful, and the patient was discharged on POD 5. However, during outpatient follow-up, his anemia persisted, necessitating frequent blood transfusions. Follow-up EGD showed no improvement in the GAVE lesions (Fig. 3). Therefore, a laparoscopic distal gastrectomy was ultimately performed at 3 months after the initial surgery. Intraoperatively, the right gastroepiploic artery and vein had already been divided from the gastric angle along the greater curvature to the duodenal bulb during the initial procedure. The right gastric artery and vein, along with the superior duodenal artery, were subsequently dissected along the gastric wall. The duodenum was transected using a 60-mm blue cartridge linear stapler (ECHELON 3000 Stapler; Johnson & Johnson, New Brunswick, NJ, USA) (Fig. 4A), and the stomach was resected near the gastric angle using two 60-mm blue cartridge linear staplers (Fig. 4B), with removal of the resected specimen. A Billroth I reconstruction was performed with a delta-shaped anastomosis using 45- and 60-mm blue cartridge staplers (Fig. 4C). The total operative time was 196 min, with an estimated blood loss of 200 g.

Fig. 1. Endoscopic and contrast-enhanced CT findings before surgery. (A) EGD showing the characteristic “watermelon stomach” appearance, with prominent erythematous tortuous folds in the antrum, consistent with GAVE. (B) Contrast-enhanced CT demonstrating dilated omental arteries and veins.

Fig. 1

GAVE, gastric antral vascular ectasia; EGD, esophagogastroduodenoscopy

Fig. 2. Intraoperative findings for gastric antral devascularization. (A) The omental artery and vein were dissected along the stomach wall, detaching the omental attachment. (B) Blood flow assessment using ICG fluorescence imaging at 40 s after ICG injection. (C) ICG fluorescence imaging at 60 s after ICG injection.

Fig. 2

ICG, indocyanine green

Fig. 3. Endoscopic findings of the GAVE lesions. The endoscopic findings after the vascular resection are shown.

Fig. 3

GAVE, gastric antral vascular ectasia

Fig. 4. Distal gastrectomy. (A) Resection of the duodenum using a 60-mm blue cartridge linear stapler. (B) Resection of the stomach using two 60-mm blue cartridge linear staplers. (C) Reconstruction using a delta-shaped anastomosis with Billroth I reconstruction using 45- and 60-mm blue cartridge staplers.

Fig. 4

Macroscopic examination of the resected specimen revealed a reddish lesion in the gastric antrum (Fig. 5A). Pathological findings demonstrated sporadic capillary proliferation within the lamina propria mucosa and telangiectasia, as well as multiple small and large capillaries in the submucosa (Fig. 5B). In certain areas, dilated arteries and veins extended from the subserosa through the muscularis propria into the submucosa, suggestive of an arteriovenous malformation. The final pathological diagnosis was a complex vascular malformation (Fig. 5C). The postoperative course was uneventful, and the patient was discharged on POD 6. No recurrence of anemia has been observed since the procedure.

Fig. 5. Surgical specimen and histological findings (hematoxylin–eosin and immunohistochemical staining). (A) Photograph of the resected specimen showing prominent reddish telangiectasia in the antrum. (B) Histopathological examination revealing dilated capillaries and arteries within the submucosa, along with arteries and veins penetrating the muscularis propria from the subserosal layer (original magnification, ×5). (C) Elastica van Gieson staining highlighting the dilated arteries and veins within the submucosa, indicative of a complex arteriovenous malformation (original magnification, ×20).

Fig. 5

DISCUSSION

GAVE accounts for approximately 4% of non-variceal upper gastrointestinal bleeding cases and is characterized endoscopically by a distinctive “watermelon stomach” appearance due to radially distributed dilated capillaries in the gastric antrum.1,2) The pathogenesis of GAVE remains incompletely understood, but several mechanisms have been proposed, including antral hyperperistalsis leading to pyloric prolapse, vasodilatory effects of gastrin, autoimmune factors, portal hypertension, and metabolic derangements associated with renal failure.4) While GAVE can lead to chronic gastrointestinal bleeding and subsequent anemia, active bleeding is infrequently observed during endoscopic examination. Although GAVE is most commonly associated with liver cirrhosis,5) a wide range of other comorbidities, including autoimmune disorders,6) cardiac diseases,7) and chronic kidney disease,8) have also been reported.

Minimally invasive endoscopic therapies have become the first-line treatment for GAVE. Various thermal coagulation techniques have shown efficacy for GAVE, including laser photocoagulation,9) radiofrequency ablation,10) the heat probe method,11) and APC.1214) Among these, APC is widely favored due to its ease of use, ability to coagulate large areas, and high therapeutic efficacy. However, recurrence and rebleeding are common, necessitating repeated interventions in many cases.15,16)

For cases refractory to endoscopic therapy, a surgical intervention may be required.17,18) We performed a literature review using the terms “gastric antral vascular ectasia,” “GAVE,” “surgery,” and “gastrectomy” in the PubMed database and identified 12 surgical cases of APC-resistant GAVE (Table 1).2,12,1726) The surgical treatment for GAVE was gastrectomy in all cases. Four patients had liver disease, and 3 had renal disease. Bleeding was successfully controlled in all patients after surgery. In the present case, the patient exhibited resistance to endoscopic treatment, necessitating a surgical intervention. In this case, contrast CT showed dilation of the right gastroepiploic artery and vein, and we hypothesized that the cause may have been the development of blood vessels in the antrum. Inspired by the Hassab procedure for gastroesophageal varices,27) we devised a technique for vascular devascularization of the gastric antrum. However, because there are no previous reports of laparoscopic devascularization for GAVE without concomitant gastrectomy in the PubMed database, the efficacy of antral vascular devascularization could not be confirmed. Given the patient’s strong preference for preservation of the stomach, we chose to perform a less invasive occlusion rather than a gastrectomy. However, the anemia persisted postoperatively, and follow-up EGD showed no improvement in the GAVE lesions. The limited efficacy of devascularization in this case may be attributable to the rich intramural vascular network of the stomach,28) resulting in insufficient reduction of the blood flow at the resection site. Histopathological examination of the resected specimen revealed capillary proliferation and the presence of arteriovenous anastomoses within the lesions. These findings suggest that ligation of the right gastroepiploic artery and vein alone may not have adequately disrupted the antral capillary blood supply. Because resection of the blood vessels on the lesser curvature side, which is the reflux area of the right gastric artery, could have caused ischemia in the pylorus, we considered that treatment by vascular blockade would be difficult, and therefore chose a distal gastrectomy.

Table 1. Twelve surgical cases of APC-resistant GAVE.

Case Author Age Sex Comorbidity Endoscopic findings Initial treatment Surgical procedure
1 Jouanolle et al.19) 66 F Systemic sclerosis Watermelon APC ODG
2 Probst et al.12) 51 F None Watermelon APC ODG
3 Sherman et al.18) 78 F None Watermelon APC LADG
4 Pljesa et al.20) 54 F Chronic pyelonephritis Watermelon APC and EBL OTG
5 Belle et al.21) 71 F None APC LADG
6 Yildiz et al.22) 62 F None Watermelon APC ODG
7 Jin et al.2) 75 M None Watermelon APC ODG
8 Becq et al.23) 67 M Cirrhosis APC and TIPS ODG
9 Lim et al.24) 56 F DVT, PTE Watermelon APC LADG
10 Alsaeed et al.17) 54 F ESRD Watermelon APC LAsTG
11 Itagaki et al.25) 62 M Cirrhosis, diabetes, ESRD DAVE APC ODG
12 Girão de Caires et al.26) 75 F Chronic hepatitis Watermelon APC and EBL ODG

APC, argon plasma coagulation; DAVE, diffuse gastric antral vascular ectasia; DVT, deep vein thrombosis; EBL, endoscopic band ligation; ESRD, end-stage renal disease; F, female; GAVE, gastric antral vascular ectasia; LADG, laparoscopy-assisted distal gastrectomy; LAsTG, laparoscopic assisted subtotal gastrectomy; M, male; ODG, open distal gastrectomy; OTG, open total gastrectomy; PTE, pulmonary thromboembolism; TIPS, transjugular intrahepatic portosystemic shunt

Pathologically, GAVE is characterized by capillary dilation and proliferation in the lamina propria, thrombotic occlusion within capillaries, and fibromuscular hyperplasia.29) The lesions can extend beyond the lamina propria into the submucosa, and this may contribute to the high recurrence rate after endoscopic treatment of the mucosal surface alone. In the present case, a histological examination revealed dilated arteries and veins extending from the subserosa through the muscularis propria into the submucosa, suggestive of an underlying arteriovenous malformation. Although dilated capillaries deep in the submucosa have been described in APC-refractory cases,30) there are no reports of abnormal blood vessels extending from the subserosa through the muscularis propria to the submucosa. The present case demonstrated the characteristic features of GAVE, including dilated capillaries within the lamina propria and submucosa. In addition to these findings, paired arteries and veins penetrating from the serosa through the muscularis propria were observed in deeper layers. These vessel structures exhibited arteriovenous transition, consistent with a vascular malformation. Accordingly, from a pathological perspective, this lesion can be classified as a form of vascular malformation in a broad sense. While the exact etiology of GAVE remains unclear, the presence of such vascular anomalies may be associated with cases that are refractory to endoscopic therapies such as APC.

CONCLUSIONS

For GAVE cases that are refractory to endoscopic treatment, devascularization alone may not provide sufficient therapeutic benefits. The present case highlights the potential limitations of devascularization and supports the efficacy of a distal gastrectomy as the definitive treatment option, leading to a favorable clinical outcome.

ACKNOWLEDGMENTS

We thank Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.

DECLARATIONS

Funding

No funding was received for this study.

Authors’ contributions

KM wrote the manuscript.

TY edited the manuscript.

KI supervised the editing of the manuscript.

The remaining co-authors collected the data and discussed the content of the manuscript.

All authors read and approved the final manuscript.

Availability of data and materials

All data generated or analyzed during this study are included in the published article.

Ethics approval and consent to participate

This work does not require ethical considerations or approval.

Informed consent to participate in this study was obtained from the patient.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Competing interests

The authors declare that they have no conflicts of interest.

REFERENCES

  • 1).Gretz JE, Achem SR. The watermelon stomach: clinical presentation, diagnosis, and treatment. Am J Gastroenterol 1998; 93: 890–5. [DOI] [PubMed] [Google Scholar]
  • 2).Jin T, Fei BY, Zheng WH, et al. Successful treatment of refractory gastric antral vascular ectasia by distal gastrectomy: a case report. World J Gastroenterol 2014; 20: 14073–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3).Boltin D, Gingold-Belfer R, Lichtenstein L, et al. Long-term treatment outcome of patients with gastric vascular ectasia treated with argon plasma coagulation. Eur J Gastroenterol Hepatol 2014; 26: 588–93. [DOI] [PubMed] [Google Scholar]
  • 4).Burak KW, Lee SS, Beck PL. Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome. Gut 2001; 49: 866–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5).Ikeda M, Hayashi N, Imamura E, et al. Endoscopic follow-up study of development of gastric antral vascular ectasia associated with liver cirrhosis. J Gastroenterol 1997; 32: 587–92. [DOI] [PubMed] [Google Scholar]
  • 6).Morrisroe K, Hansen D, Stevens W, et al. Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival. Arthritis Res Ther 2022; 24: 103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7).Dosi RV, Ambaliya AP, Patell RD, et al. Gastric antral vascular ectasia with aortic stenosis: Heydes syndrome. Indian J Med Sci 2012; 66: 86–9. [PubMed] [Google Scholar]
  • 8).Iguchi A, James Kazama J, Komatsu M, et al. Three cases of gastric antral vascular ectasia in chronic renal failure. Case Rep Nephrol Urol 2011; 1: 15–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9).Bourke MJ, Hope RL, Boyd P, et al. Endoscopic laser therapy for watermelon stomach. J Gastroenterol Hepatol 1996; 11: 832–4. [DOI] [PubMed] [Google Scholar]
  • 10).Binmoeller KF, Katon RM. Bipolar electrocoagulation for watermelon stomach. Gastrointest Endosc 1990; 36: 399–402. [DOI] [PubMed] [Google Scholar]
  • 11).Petrini JL Jr., Johnston JH. Heat probe treatment for antral vascular ectasia. Gastrointest Endosc 1989; 35: 324–8. [DOI] [PubMed] [Google Scholar]
  • 12).Probst A, Scheubel R, Wienbeck M. Treatment of watermelon stomach (GAVE syndrome) by means of endoscopic argon plasma coagulation (APC): long-term outcome. Z Gastroenterol 2001; 39: 447–52. [DOI] [PubMed] [Google Scholar]
  • 13).Wahab PJ, Mulder CJ, den Hartog G, et al. Argon plasma coagulation in flexible gastrointestinal endoscopy: pilot experiences. Endoscopy 1997; 29: 176–81. [DOI] [PubMed] [Google Scholar]
  • 14).Canard JM, Vedrenne B. Clinical application of argon plasma coagulation in gastrointestinal endoscopy: has the time come to replace the laser? Endoscopy 2001; 33: 353–7. [DOI] [PubMed] [Google Scholar]
  • 15).Yusoff I, Brennan F, Ormonde D, et al. Argon plasma coagulation for treatment of watermelon stomach. Endoscopy 2002; 34: 407–10. [DOI] [PubMed] [Google Scholar]
  • 16).Roman S, Saurin JC, Dumortier J, et al. Tolerance and efficacy of argon plasma coagulation for controlling bleeding in patients with typical and atypical manifestations of watermelon stomach. Endoscopy 2003; 35: 1024–8. [DOI] [PubMed] [Google Scholar]
  • 17).Alsaeed BH, AlAbdulqader AA, Al-Qadhi AA, et al. Successful surgical management of gastric antral vascular ectasia in a patient with end-stage renal disease: a case report and literature review. Am J Case Rep 2023; 24: e938543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18).Sherman V, Klassen DR, Feldman LS, et al. Laparoscopic antrectomy: a novel approach to treating watermelon stomach. J Am Coll Surg 2003; 197: 864–7. [DOI] [PubMed] [Google Scholar]
  • 19).Jouanolle H, Bretagne JF, Ramée MP, et al. Antral vascular ectasia and scleroderma: endoscopic, radiologic and anatomopathologic aspects of an uncommon association. Gastroenterol Clin Biol 1989; 13: 217–21. (in French) [PubMed] [Google Scholar]
  • 20).Pljesa S, Golubovic G, Tomasevic R, et al. “Watermelon stomach” in patients on chronic hemodialysis. Ren Fail 2005; 27: 643–6. [DOI] [PubMed] [Google Scholar]
  • 21).Belle JM, Feiler MJ, Pappas TN. Laparoscopic surgical treatment for refractory gastric antral vascular ectasia: a case report and review. Surg Laparosc Endosc Percutan Tech 2009; 19: e189–93. [DOI] [PubMed] [Google Scholar]
  • 22).Yildiz B, Sokmensuer C, Kaynaroglu V. Chronic anemia due to watermelon stomach. Ann Saudi Med 2010; 30: 156–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23).Becq A, Ozenne V, Plessier A, et al. Transjugular intrahepatic portosystemic shunt as bridge-to-surgery in refractory gastric antral vascular ectasia. World J Gastroenterol 2015; 21: 5749–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24).Lim D, Liu S, Meytes V, et al. Laparoscopic subtotal gastrectomy with Roux-en-Y reconstruction for long-term anticoagulation in gastric antral vascular ectasia syndrome. BMJ Case Rep 2019; 12: e230844. [Google Scholar]
  • 25).Itagaki H, Suzuki K, Endo T. A case of refractory gastric antral vascular ectasia treated successfully with distal gastrectomy and Billroth II reconstruction. Cureus 2023; 15: e34875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26).Girão de Caires F, Nunes M, Damiao F, et al. Anemia secondary to gastric antral vascular ectasia successfully treated with antral gastrectomy. Cureus 2024; 16: e69663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27).Hassab MA. Gastroesophageal decongestion and splenectomy in the treatment of esophageal varices in bilharzial cirrhosis: further studies with a report on 355 operations. Surgery 1967; 61: 169–76. [PubMed] [Google Scholar]
  • 28).Tang SJ, Daram SR, Wu R, et al. Pathogenesis, diagnosis, and management of gastric ischemia. Clin Gastroenterol Hepatol 2014; 12: 246–52 e1. [DOI] [PubMed] [Google Scholar]
  • 29).Suit PF, Petras RE, Bauer TW, et al. Gastric antral vascular ectasia. A histologic and morphometric study of “the watermelon stomach”. Am J Surg Pathol 1987; 11: 750–1. [PubMed] [Google Scholar]
  • 30).Hashimoto S, Kobayashi M, Ajioka Y, et al. A case of recurrent gastric vascular antral ectasia treated with endoscopic submucosal dissection. Gastroenterol Endosc 2010; 52: 3290–5. (in Japanese) [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data generated or analyzed during this study are included in the published article.


Articles from Surgical Case Reports are provided here courtesy of Japan Surgical Society

RESOURCES